Job Watch

Illumina: Staff Deep Learning / AI Engineer

New Scientist - Bioinformatics - Fri, 2019-06-28 07:19
Competitive: Illumina: Position Summary:  The Staff Deep Learning/AI Engineer in Illumina’s Research group will focus on applying bioinformatics algorithms, machine learning San Francisco, California (US)
Categories: Job Watch

Illumina: Sr/Software Engineer (C#)

New Scientist - Bioinformatics - Fri, 2019-06-28 07:19
Competitive: Illumina: Responsibilities:Work as part of Agile scrum teams to design, implement, and test the instrument control software that powers our industry-leading DNA Asia
Categories: Job Watch

Illumina: Python Software Engineer

New Scientist - Bioinformatics - Fri, 2019-06-28 07:19
Competitive: Illumina: Do you want to join the team developing software for one of the largest clinical sequencing laboratories in the world and make a positive impact on th Hinxton, Cambridgeshire, England
Categories: Job Watch

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-20-020 from the NIH Guide for Grants and Contracts. This FOA aims to competitively renew Centers known as Nathan Shock Centers of Excellence in Basic Biology of Aging (NSC).

Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-20-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to develop and maintain a Nathan Shock Centers Coordinating Center (NSC3). Applicants should be familiar with Nathan Shock Centers (NSC) activities, but they do not need to be part of an active Center. Major activities of the proposed NSC3 will include improving visibility of the NSC nationally and internationally, improving collaboration and coordination among NSC, enhancing NSC training activities, facilitating the sharing of resources, and interacting with NIA and NSC to develop strategies and plans for further development.

Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)

Funding Opportunity PAR-19-310 from the NIH Guide for Grants and Contracts. This Funding Opportunity from the National Institute on Drug Abuse (NIDA) will use a NIH Small Research Grant (R03) award mechanism to support studies that apply affective, cognitive and behavioral science approaches to research questions relevant to substance use disorders (SUD). With this R03 mechanism, NIDA aims to seed innovative affective, cognitive and behavioral hypotheses, models, and methods in preclinical and clinical SUD research. The B/START R03 is intended for recently-independent investigators with expertise in behavioral science as well as established investigators who are using behavioral science approaches to SUD for the first time. Studies supported by B/START are expected to produce a coherent set of preliminary findings that would inform the design of a more complete study and serve as preliminary data supporting feasibility or scientific rationale in an R01, R21 or similar application.

NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed)

Funding Opportunity RFA-NS-19-040 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Child Neurologist Career Development Program (CNCDP) is to facilitate and support the research career development of child neurologists who have made a commitment to independent research careers. The CNCDP is a single national program, implemented by one or more PD/PIs and, if applicable, co- directors (at least one of whom is the PD/PI), together with an advisory committee composed of basic and clinical investigators who have a strong record of funded research and successful training of clinician scientists. The CNCDP will generally provide three consecutive years of support to individuals to provide them with the knowledge, tools and research experience that will enable them to develop a significant research project funded by an individual career development award or research grant. This Funding Opportunity Announcement (FOA) does not allow appointed scholars to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional)

Funding Opportunity RFA-MH-20-310 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications in two related but distinct areas. The first area is in the development and testing of novel tools and methods of neuromodulation that go beyond the existing forms of neural stimulation. The second distinct area that this FOA seeks to encourage is the optimization of existing stimulation methods.

Science of Behavior Change (SOBC) Resource and Coordinating Center (U24 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-20-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to continue support for a Resource and Coordinating Center (RCC) for the NIH Science of Behavior Change (SOBC) program, which was supported for the past ten years by the NIH Common Fund. The goal of the RCC will be to lead, participate in, and support activities that will maximize the creativity, productivity, scientific rigor, and dissemination of SOBC products and approaches to meaningfully impact health behaviors.

BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-EB-19-001 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aims to support early stage development of entirely new and novel noninvasive human brain imaging technologies and methods that will lead to transformative advances in our understanding of the human brain. The FOA solicits unusually bold and potentially transformative approaches and supports small-scale, proof-of-concept development based on exceptionally innovative, original and/or unconventional concepts.

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed)

Funding Opportunity RFA-EB-19-002 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools. This FOA represents the second stage of the tool/technology development effort that started with RFA-MH-14-217 and RFA-MH-15-200

Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-MH-20-300 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the development or application of advanced computational and statistical tools to integrate brain tissue and single-cell genomic data in order to advance our understanding of the cell type-specific gene regulatory networks and biological pathways involved in the pathogenesis and pathophysiology of mental disorders.

Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-20-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites early stage innovative and exploratory research focusing on understanding the regulation of brain regional and cell type-specific protein dynamics in Alzheimer's disease (AD). In particular, this FOA seeks applications proposing to develop novel proteomic platforms and animal models to further understanding of the alteration of a single-cell neuronal cell proteome in the central nervous system (CNS) during the course of aging and AD.

Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-20-042 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites innovative research focused on understanding the regulation of brain regional and cell- type- specific proteome dynamics in Alzheimers disease (AD).

Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)

Funding Opportunity RFA-AG-20-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications proposing to conduct research involving pragmatic clinical trials on dissemination and implementation of practical approaches to hypertension treatment and control strategies among older adults with multimorbidity in order to prevent sequelae, including mild cognitive impairment and dementia.

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)

Funding Opportunity RFA-AG-20-018 from the NIH Guide for Grants and Contracts. The goal of the GEMSSTAR program is to provide support for early-career physician-scientists trained in medical or surgical specialties or early-career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research. To achieve this goal, the GEMSSTAR Funding Opportunity Announcement (FOA) provides small grants to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects.

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)

Funding Opportunity RFA-DA-20-008 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology.

Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)

Funding Opportunity RFA-DA-20-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology.

Pages

Subscribe to Anil Jegga aggregator - Job Watch